Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Week in Review: A new Class I recall | FDA approves oral semaglutide for CV benefits | ASE leads push to revise CPT code
Sunday, October 26, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

FDA confirms Class I recall for Johnson & Johnson devices due to durability concerns

The issue, first reported in September, was linked to five patient injuries. Devices not being actively used should be returned to Johnson & Johnson MedTech for updates.

READ MORE >
Johnson & Johnson MedTech Automated Impella Controller
Share on Twitter Share on Facebook Share on Linkedin

FDA confirms Class I recall for Johnson & Johnson devices due to durability concerns

Share on Twitter Share on Facebook Share on Linkedin
Johnson & Johnson MedTech Automated Impella Controller
The issue, first reported in September, was linked to five patient injuries. Devices not being actively used should be returned to Johnson & Johnson MedTech for updates.
READ MORE >

Cardiology leader, a ’40 under 40’ winner, arrested for leaving baby on beach

Both parents were arrested for neglect and then released the next day after posting a $1,000 bond. The child was unharmed.

READ MORE >
handcuffs arrested arrest jail
Share on Twitter Share on Facebook Share on Linkedin

Cardiology leader, a ’40 under 40’ winner, arrested for leaving baby on beach

Share on Twitter Share on Facebook Share on Linkedin
handcuffs arrested arrest jail
Both parents were arrested for neglect and then released the next day after posting a $1,000 bond. The child was unharmed.
READ MORE >

FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes

Rybelsus from Novo Nordisk is officially the first oral GLP-1 drug approved for this indication. The FDA's decision was based on the SOUL trial, which included data from more than 9,000 patients with type 2 diabetes.

READ MORE >
approval regulations checkmark doctor
Share on Twitter Share on Facebook Share on Linkedin

FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes

Share on Twitter Share on Facebook Share on Linkedin
approval regulations checkmark doctor
Rybelsus from Novo Nordisk is officially the first oral GLP-1 drug approved for this indication. The FDA's decision was based on the SOUL trial, which included data from more than 9,000 patients with type 2 diabetes.
READ MORE >

Most adults know nothing about CKM syndrome—but it impacts nearly everyone

Nearly 90% of adults are believed to already have at least one risk factor of CKM syndrome. The American Heart Association hopes patient education and physician collaborations can help increase awareness about this dangerous condition.

READ MORE >
old woman or doctor shaking hands with patient
Share on Twitter Share on Facebook Share on Linkedin

Most adults know nothing about CKM syndrome—but it impacts nearly everyone

Share on Twitter Share on Facebook Share on Linkedin
old woman or doctor shaking hands with patient
Nearly 90% of adults are believed to already have at least one risk factor of CKM syndrome. The American Heart Association hopes patient education and physician collaborations can help increase awareness about this dangerous condition.
READ MORE >

Medtronic announces new AI partnership focused on improving TAVR care

Participating TAVR programs will receive AI-powered recommendations courtesy of DASI Simulations.

READ MORE >
heart data AI algorithm cardiologist doctor
Share on Twitter Share on Facebook Share on Linkedin

Medtronic announces new AI partnership focused on improving TAVR care

Share on Twitter Share on Facebook Share on Linkedin
heart data AI algorithm cardiologist doctor
Participating TAVR programs will receive AI-powered recommendations courtesy of DASI Simulations.
READ MORE >

Nuclear cardiology expands beyond perfusion imaging as it enters a new era

Beyond amyloidosis, nuclear cardiology is also increasingly used to image inflammation and infection in the myocardium, especially in diseases such as cardiac sarcoidosis and myocarditis.

READ MORE >
Nuclear cardiology is entering a new era—one that goes well beyond the traditional focus on myocardial perfusion imaging. According to Marcelo Di Carli, MD, editor-in-chief of the Journal of Nuclear Cardiology and chief of the Division of Nuclear Medicine at Brigham and Women’s Hospital, the field is rapidly expanding into diagnosing and monitoring complex cardiac diseases such as amyloidosis, sarcoidosis, myocarditis, and cardiac infections.
Share on Twitter Share on Facebook Share on Linkedin

Nuclear cardiology expands beyond perfusion imaging as it enters a new era

Share on Twitter Share on Facebook Share on Linkedin
Nuclear cardiology is entering a new era—one that goes well beyond the traditional focus on myocardial perfusion imaging. According to Marcelo Di Carli, MD, editor-in-chief of the Journal of Nuclear Cardiology and chief of the Division of Nuclear Medicine at Brigham and Women’s Hospital, the field is rapidly expanding into diagnosing and monitoring complex cardiac diseases such as amyloidosis, sarcoidosis, myocarditis, and cardiac infections.
Beyond amyloidosis, nuclear cardiology is also increasingly used to image inflammation and infection in the myocardium, especially in diseases such as cardiac sarcoidosis and myocarditis.
READ MORE >

ASE leading push to revise CPT code for interventional echocardiography

The pressure is on for ASE and other societies to create a new CPT code for the use of interventional echocardiography during structural heart procedures.

READ MORE >
Cardiovascular ultrasound showing Philips Echo Navigator with TEE angio fusion for a tricuspid valve intervention TTVR TCT 2024 DF
Share on Twitter Share on Facebook Share on Linkedin

ASE leading push to revise CPT code for interventional echocardiography

Share on Twitter Share on Facebook Share on Linkedin
Cardiovascular ultrasound showing Philips Echo Navigator with TEE angio fusion for a tricuspid valve intervention TTVR TCT 2024 DF
The pressure is on for ASE and other societies to create a new CPT code for the use of interventional echocardiography during structural heart procedures.
READ MORE >

New biodegradable PFO closure device shows early potential

Researchers tracked patients for two years, using echocardiography to confirm the devices had completely vanished. Additional studies will still be required.

READ MORE >
The novel biodegradable PFO closure device is primarily composed of a device support frame, a flow-blocking membrane, suture thread, a shape ring (yellow arrow), and shape thread (white arrows). A: Unlocked device. B: Locked device. Images and caption courtesy of Circulation.
Share on Twitter Share on Facebook Share on Linkedin

New biodegradable PFO closure device shows early potential

Share on Twitter Share on Facebook Share on Linkedin
The novel biodegradable PFO closure device is primarily composed of a device support frame, a flow-blocking membrane, suture thread, a shape ring (yellow arrow), and shape thread (white arrows). A: Unlocked device. B: Locked device. Images and caption courtesy of Circulation.
Researchers tracked patients for two years, using echocardiography to confirm the devices had completely vanished. Additional studies will still be required.
READ MORE >

Judge files lawsuit over husband’s death—alleges heart symptoms were mismanaged

The patient reported chest pain multiple times and had a family history of heart disease. According to the lawsuit, however, he was never referred to a cardiologist. 

READ MORE >
An Illinois appellate judge upheld a pervious trial victory that cleared and central Illinois cardiologist Amit Dande, MD, and Prairie Cardiovascular Consults LLP of alleged misdiagnosis of the severity of a patient's heart condition that led to his death prior to a schedule percutaneous coronary intervention (PCI).
Share on Twitter Share on Facebook Share on Linkedin

Judge files lawsuit over husband’s death—alleges heart symptoms were mismanaged

Share on Twitter Share on Facebook Share on Linkedin
An Illinois appellate judge upheld a pervious trial victory that cleared and central Illinois cardiologist Amit Dande, MD, and Prairie Cardiovascular Consults LLP of alleged misdiagnosis of the severity of a patient's heart condition that led to his death prior to a schedule percutaneous coronary intervention (PCI).
The patient reported chest pain multiple times and had a family history of heart disease. According to the lawsuit, however, he was never referred to a cardiologist. 
READ MORE >

PET holds promise for carotid plaque assessments

PET has already gained significant momentum in recent years. Now, researchers are pointing to another possible use for the popular imaging modality: assessing carotid artery atherosclerosis.

READ MORE >
Positron emission tomography (PET) nuclear imaging has seen rapid expansion in cardiology and oncology due to its improve accuracy over SPECT and its ability to expand into new areas of cardiovascular imaging. A new review in the American Heart Association journal Stroke outlines another possible use of PET to assess carotid artery atherosclerosis for stroke prevention. Figure courtesy Stroke, https://www.ahajournals.org/doi/10.1161/STROKEAHA.125.050399
Share on Twitter Share on Facebook Share on Linkedin

PET holds promise for carotid plaque assessments

Share on Twitter Share on Facebook Share on Linkedin
Positron emission tomography (PET) nuclear imaging has seen rapid expansion in cardiology and oncology due to its improve accuracy over SPECT and its ability to expand into new areas of cardiovascular imaging. A new review in the American Heart Association journal Stroke outlines another possible use of PET to assess carotid artery atherosclerosis for stroke prevention. Figure courtesy Stroke, https://www.ahajournals.org/doi/10.1161/STROKEAHA.125.050399
PET has already gained significant momentum in recent years. Now, researchers are pointing to another possible use for the popular imaging modality: assessing carotid artery atherosclerosis.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Choosing PET over SPECT | Key M&A trends in cardiology | Rising healthcare costs | Surgical backup during TAVR: Is it necessary?
Week in Review: A new Class I recall | FDA approves oral semaglutide for CV benefits | ASE leads push to revise CPT code
Surgical backup during TAVR | What SCAI learned from its members | FDA clears AI-enabled stethoscopes | High-risk inflammation
Safety issues for Abbott & Edwards | Heart surgeons earn more than $1M per year | Coronary plaque imaging keeps improving
Planning ahead with CCTA | FDA impressed by resorbable scaffold for PCI | Hillary Clinton at STS meeting | Firefighter deaths
Why AI will not replace cardiologists | Improving imaging workflows | Reimbursement trends | Cardiology tech in the spotlight
FDA approves Edwards valve for T-TEER | TAVR vs. SAVR | Elucid's new AI software | Tracking a ‘catastrophic’ PCI complication
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup